|
Apr 3
|
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
|
|
Mar 25
|
Ampio Announces Voluntary Delisting and SEC Deregistration
|
|
Oct 5
|
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
|
|
Oct 4
|
Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
|
|
Aug 31
|
Ampio Pharmaceuticals Announces Reverse Stock Split
|